MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12879-026-12951-1

Медицинская библиотека · BMC infectious diseases · 2026

Bioactive adrenomedullin as a point-of-care biomarker in emergency department patients with suspected severe infections: an exploratory analysis.

Maier-Stocker Constantin, Hupf Julian, Zinsser-Krys Jillena, Zimmermann Markus, Hanses Frank

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Early identification and treatment of patients with severe infections or sepsis remains challenging, and suitable biomarkers are lacking. This prospective exploratory pilot study aimed to evaluate the potential of point-of-care bioactive adrenomedullin (POC bio-ADM) in predicting bacteremia in patients presenting to the emergency department (ED) with suspected severe infections. Secondary objectives included its association with any infection, in-hospital mortality, intensive care unit (ICU) admission, and ICU length of stay.

METHODS

In this prospective exploratory pilot cohort study, adult patients presenting to the ED of a German university hospital between December 2022 and September 2023 were enrolled. POC bio-ADM levels were analyzed using univariate and multivariable binary logistic regression and compared to established sepsis biomarkers (PCT, CRP, lactate).

RESULTS

47 patients were included in the final analysis. POC bio-ADM was positive (> 45 pg/ml) in 38.3% (95% CI: 25.8–52.6%). Bacteremia was found in 34.0% (95% CI: 22.2–48.3%), and 78.7% (95% CI: 65.1–88.8%) had an infection. Positive POC bio-ADM was associated with significantly higher rates of bacteremia (55.6% vs. 20.7%). In the multivariable analysis, a positive POC bio-ADM was associated with an odds ratio (OR) of 5.318 (95% CI: 1.217–23.243) for bacteremia. Attributable in-hospital mortality was higher in patients with elevated POC bio-ADM (44.4% vs. 3.6%; OR: 21.6, 95% CI: 2.4-195.3).

CONCLUSION

This small, single-centre pilot exploratory study suggests that POC bio-ADM may help identify ED patients with suspected severe infection at increased risk of bacteremia and in-hospital mortality; these findings are hypothesis-generating and require confirmation in larger cohorts.

Для цитирования: Maier-Stocker Constantin, Hupf Julian, Zinsser-Krys Jillena, Zimmermann Markus, Hanses Frank. Bioactive adrenomedullin as a point-of-care biomarker in emergency department patients with suspected severe infections: an exploratory analysis.. BMC infectious diseases. 2026. DOI: 10.1186/s12879-026-12951-1.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.